Selected research
Industry Research
Endocrinology Drugs Industry Research Report 2026
Market perspective
The global Endocrinology Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Endocrinology Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Endocrinology Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Endocrinology Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Endocrinology Drugs include Sanofi, Novo Nordisk, Merck, Eli Lilly, AbbVie and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Endocrinology Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Endocrinology Drugs Market by Company
Sanofi
Novo Nordisk
Merck
Eli Lilly
AbbVie
AstraZeneca
Endocrinology Drugs Segment by Type
Diabetes Drugs
Human Growth Hormone Drugs
Thyroid Hormone Disorder Drugs
Testosterone Replacement Drugs
Endocrinology Drugs Segment by Application
Ambulatory Care Centres
Commercial Laboratories
Hospitals
Other Setting
Endocrinology Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrinology Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endocrinology Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrinology Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Endocrinology Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Endocrinology Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Endocrinology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Diabetes Drugs
- Human Growth Hormone Drugs
- Thyroid Hormone Disorder Drugs
- Testosterone Replacement Drugs
Applications
- Ambulatory Care Centres
- Commercial Laboratories
- Hospitals
- Other Setting
Companies covered
- Sanofi
- Novo Nordisk
- Merck
- Eli Lilly
- AbbVie
- AstraZeneca
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Endocrinology Drugs Market Size (2021-2032)
- 2.2.2 Global Endocrinology Drugs Sales (2021-2032)
- 2.2.3 Global Endocrinology Drugs Market Average Price (2021-2032)
- 2.3 Endocrinology Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Diabetes Drugs
- 2.3.3 Human Growth Hormone Drugs
- 2.3.4 Thyroid Hormone Disorder Drugs
- 2.3.5 Testosterone Replacement Drugs
- 2.4 Endocrinology Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Ambulatory Care Centres
- 2.4.3 Commercial Laboratories
- 2.4.4 Hospitals
- 2.4.5 Other Setting
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Endocrinology Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Endocrinology Drugs Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Endocrinology Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Endocrinology Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Endocrinology Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Endocrinology Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Endocrinology Drugs, Product Type & Application
- 3.8 Global Manufacturers of Endocrinology Drugs, Established Date
- 3.9 Global Endocrinology Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Endocrinology Drugs Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Novo Nordisk
- 4.2.1 Novo Nordisk Company Information
- 4.2.2 Novo Nordisk Business Overview
- 4.2.3 Novo Nordisk Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novo Nordisk Endocrinology Drugs Product Portfolio
- 4.2.5 Novo Nordisk Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Endocrinology Drugs Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Eli Lilly
- 4.4.1 Eli Lilly Company Information
- 4.4.2 Eli Lilly Business Overview
- 4.4.3 Eli Lilly Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Eli Lilly Endocrinology Drugs Product Portfolio
- 4.4.5 Eli Lilly Recent Developments
- 4.5 AbbVie
- 4.5.1 AbbVie Company Information
- 4.5.2 AbbVie Business Overview
- 4.5.3 AbbVie Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 AbbVie Endocrinology Drugs Product Portfolio
- 4.5.5 AbbVie Recent Developments
- 4.6 AstraZeneca
- 4.6.1 AstraZeneca Company Information
- 4.6.2 AstraZeneca Business Overview
- 4.6.3 AstraZeneca Endocrinology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AstraZeneca Endocrinology Drugs Product Portfolio
- 4.6.5 AstraZeneca Recent Developments
5 Global Endocrinology Drugs Market Scenario by Region
- 5.1 Global Endocrinology Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Endocrinology Drugs Sales by Region: 2021-2032
- 5.2.1 Global Endocrinology Drugs Sales by Region: 2021-2026
- 5.2.2 Global Endocrinology Drugs Sales by Region: 2027-2032
- 5.3 Global Endocrinology Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Endocrinology Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Endocrinology Drugs Revenue by Region: 2027-2032
- 5.4 North America Endocrinology Drugs Market Facts & Figures by Country
- 5.4.1 North America Endocrinology Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Endocrinology Drugs Sales by Country (2021-2032)
- 5.4.3 North America Endocrinology Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Endocrinology Drugs Market Facts & Figures by Country
- 5.5.1 Europe Endocrinology Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Endocrinology Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Endocrinology Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Endocrinology Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Endocrinology Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Endocrinology Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Endocrinology Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Endocrinology Drugs Market Facts & Figures by Country
- 5.7.1 South America Endocrinology Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Endocrinology Drugs Sales by Country (2021-2032)
- 5.7.3 South America Endocrinology Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Endocrinology Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Endocrinology Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Endocrinology Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Endocrinology Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Endocrinology Drugs Sales by Type (2021-2032)
- 6.1.1 Global Endocrinology Drugs Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Endocrinology Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Endocrinology Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Endocrinology Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Endocrinology Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Endocrinology Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Endocrinology Drugs Sales by Application (2021-2032)
- 7.1.1 Global Endocrinology Drugs Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Endocrinology Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Endocrinology Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Endocrinology Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Endocrinology Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Endocrinology Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Endocrinology Drugs Value Chain Analysis
- 8.1.1 Endocrinology Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Endocrinology Drugs Production Mode & Process
- 8.2 Endocrinology Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Endocrinology Drugs Distributors
- 8.2.3 Endocrinology Drugs Customers
9 Global Endocrinology Drugs Analyzing Market Dynamics
- 9.1 Endocrinology Drugs Industry Trends
- 9.2 Endocrinology Drugs Industry Drivers
- 9.3 Endocrinology Drugs Industry Opportunities and Challenges
- 9.4 Endocrinology Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst